RxDoctor Payments Data

Maria Bazsa, NP

Nurse Practitioner · Newton, NJNPI 1063485092

Payments from drug & device makers

$1,416in general payments, 2019–2025

Across 68 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$286
  • E.r. Squibb & Sons, L.L.C.$278
  • Merck$158
  • Medtronic$129
  • Pharmacosmos Therapeutics Inc.$120
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$112
  • plus $334 from 11 others

What the payments were for

  • Food & beverage$1,416100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,416 in reported general payments places this provider in the 85th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,542
Medicare patients
15
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol16$15,189
EliquisApixaban17$13,977
Metoprolol Succinate36$577
ClopidogrelClopidogrel Bisulfate20$532
Carvedilol24$410
Atorvastatin Calcium32$400
Pantoprazole Sodium12$313
Losartan Potassium14$284
Torsemide13$191
Rosuvastatin Calcium11$147
Amlodipine Besylate26$104
Metoprolol Tartrate13$98
Furosemide13$48

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$42$15,18916 claims
PfizerEliquis$286$13,97717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Newton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →